These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9207341)

  • 21. Methadone, adherence and protease inhibitors.
    Treat Rev; 1997 Aug; (No 25):2-3. PubMed ID: 11364614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 protease inhibitors. A review for clinicians.
    Deeks SG; Smith M; Holodniy M; Kahn JO
    JAMA; 1997 Jan; 277(2):145-53. PubMed ID: 8990341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved AIDS treatments bring life and hope--at a cost.
    Brink S
    US News World Rep; 2001 Jan; 130(4):44-6. PubMed ID: 11211336
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of HIV proteinase.
    Martin JA; Redshaw S; Thomas GJ
    Prog Med Chem; 1995; 32():239-87. PubMed ID: 8577919
    [No Abstract]   [Full Text] [Related]  

  • 25. Protease uninhibited.
    Notes Undergr; 1996 Apr; (no 32):suppl 1-2. PubMed ID: 11363451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protease inhibitors: promising new weapons against HIV.
    Isada CM
    Cleve Clin J Med; 1996; 63(4):204-8. PubMed ID: 8764690
    [No Abstract]   [Full Text] [Related]  

  • 27. A new class of anti-HIV drugs debuts.
    Am J Nurs; 1996 Jul; 96(7):59-63. PubMed ID: 8659572
    [No Abstract]   [Full Text] [Related]  

  • 28. The daunting challenge of keeping HIV suppressed.
    Cohen J
    Science; 1997 Jul; 277(5322):32-3. PubMed ID: 9229768
    [No Abstract]   [Full Text] [Related]  

  • 29. Developing long-term treatment strategies.
    PI Perspect; 1996 Sep; (No 19):11-4. PubMed ID: 11363897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.
    Erickson JW; Gulnik SV; Markowitz M
    AIDS; 1999; 13 Suppl A():S189-204. PubMed ID: 10885776
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding protease inhibitor potency: the intersection of exposure, efficacy, and resistance.
    Schapiro JM
    AIDS Read; 2001 Jun; 11(6):311-5. PubMed ID: 11449924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Resistance to protease inhibitors].
    Clotet B; Martínez-Picado J; Arrizabalaga J; Ruiz L
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):34-41. PubMed ID: 11428058
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of HIV-proteinase inhibitors.
    Gazzard B; Moyle G
    Genitourin Med; 1996 Aug; 72(4):233-5. PubMed ID: 8976824
    [No Abstract]   [Full Text] [Related]  

  • 34. Resistance: a shifting paradigm.
    Jenny-Avital ER
    AIDS Clin Care; 2002 Dec; 14(12):106. PubMed ID: 12510656
    [No Abstract]   [Full Text] [Related]  

  • 35. Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients.
    Dietrich U; Raudonat I; Wolf E; Jäger H; Husak R; Orfanos CE; Knickmann M; Knechten H; von Briesen H; Ruppach H; Immelmann A
    AIDS; 1999 Nov; 13(16):2304-5. PubMed ID: 10563717
    [No Abstract]   [Full Text] [Related]  

  • 36. Protease inhibitors: resistance, resistance, resistance.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New anti-HIV drugs and treatment strategies buoy AIDS researchers.
    Stephenson J
    JAMA; 1996 Feb; 275(8):579-80. PubMed ID: 8594227
    [No Abstract]   [Full Text] [Related]  

  • 38. Resistance: what are the implications for treatment?
    Alcorn K
    IAPAC Mon; 2004 Mar; 10(3):76. PubMed ID: 15108677
    [No Abstract]   [Full Text] [Related]  

  • 39. Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients".
    Picchio G; De Meyer S; de Béthune MP
    AIDS; 2008 Jan; 22(1):165-7. PubMed ID: 18090413
    [No Abstract]   [Full Text] [Related]  

  • 40. Conference looks at HIV drug resistance.
    Chang HE
    GMHC Treat Issues; 1995 Sep; 9(9):6-8. PubMed ID: 11362910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.